BSECompany Update4d ago · 5 Nov 2026, 04:21 pm

AS PER THE ATTACHED FILE

Continental Chemicals Ltd · 506935

✦ AI SummaryFundraise

Continental Chemicals Ltd has filed a statement of deviation and variation for the quarter ended September 2026, stating that the funds raised through a preferential issue have been fully utilized for working capital.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Continental Chemicals Ltd - 506935 - STATEMENT OF DEVIATION AND VARIATION FOR THE QUARTER ENDED SEPTEMBER, 2026

Attachments (1)

📄

9cd8269c-0f07-43e0-975e-22088c8c8e3d.pdf

pdf

Download →
View document text
Date: 05.11.2026 General Manager, Bombay Stock Exchange Limited, Phiroze Jeejeebhoy Tower, Dalal Street, Fort Mumbai, Maharashtra-400001 Scrip Code: 506935 ISIN:- INE423K01015 Subject: Statement of Deviation and Variation of Utilization of funds raised through Preferential issue for quarter ended September, 2026 Dear Sir, Pursuant to Regulation 32 of SEBI (LODR) Regulations, 2015, Please find attached herewith the Statement of Deviation and Variation of Utilization of funds raised through Preferential issue for the Quarter ended 30th September, 2026 We hereby request you to take on record of the same. Thanking you, Your faithfully For Continental Chemicals Limited Sakshi Dhawan Company Secretary (Membership No: ACS 33279) :91-120-2423316 Continental [YJ = rnisAoon aotssiat gem Chemicals Web : www.continentalchemicalsitd.com CIN :L24123UP1984PLC014111 Regd. & Head Office : A-7, Sector-7, Noida-201301 (U.P.) India GST No. : O9AAACC1412B2ZH Annexure-A Statement of Deviation / Variation in utilization of funds raised Name of listed entity Continental Chemicals Limited Mode of Fund Raising Preferential Issues Date of Raising Funds 14/10/2019 Amount Raised 1,62,50,000 Report filed for Quarter ended 30/09/2026 Monitoring Agency Not Applicable Monitoring Agency Name, if Not Applicable applicable Is there a Deviation / Variation in No use of funds raised If yes, whether the same is Not Applicable pursuant to change in terms of a contract or objects, which was approved by the shareholders If Yes, Date of shareholder Not Applicable Approval Explanation for the Deviation / Not Applicable Variation Comments of the Audit Committee Reviewed and Approved after review by audit committee Comments of the auditors, if any Not Applicable Objects for which funds have been | Company has required raised and where there has beena | the funds for working deviation, in the following table capital Original Object Modified Object, if any Origina | Modif Funds Amount | ied Utilised | of Allocat | allocat Deviation/ ion ion, if Variation any for the quarter according applicable object Company has required the funds Not Applicable 1,62,50 | Not s 0) for working capital ,000 Applic | Please Page 1 of 2 note below * Note: Please note that the funds have been fully utilized in the quarter ended 31/12/2023 Deviation or variation could mean: (a) Deviation in the objects or purposes for which the funds have been raised or (b) Deviation in the amount of funds actually utilized as against what was originally disclosed or (c) Change in terms of a contract referred to in the fund raising document i.e. prospectus, letter of offer, bes Be 2 i Mo,1 D, \; j ny aag t roogeS 74 Name of Signatory: Naresh Kumar Chibba Designation: Managing Director Date: 05.11.2026 Page 2 of2